Intrinsic Linear Heterogeneity of Amyloid β Protein Fibrils Revealed by Higher Resolution Mass-per-length Determinations*

Amyloid β proteins spontaneously form fibrils in vitro that vary in their thermodynamic stability and in morphological characteristics such as length, width, shape, longitudinal twist, and the number of component filaments. It is vitally important to determine which variant best represents the type of fibril that accumulates in Alzheimer disease. In the present study, the nature of morphological variation was examined by dark-field and transmission electron microscopy in a preparation of seeded amyloid β protein fibrils that formed at relatively low protein concentrations and exhibited remarkably high thermodynamic stability. The number of filaments comprising these fibrils changed frequently from two to six along their length, and these changes only became apparent when mass-per-length (MPL) determinations are made with sufficient resolution. The MPL results could be reproduced by a simple stochastic model with a single adjustable parameter. The presence of more than two primary filaments could not be discerned by transmission electron microscopy, and they had no apparent relationship to the longitudinal twist of the fibrils. However, the pitch of the twist was strongly affected by the pH of the negative stain. We conclude that highly stable amyloid fibrils may form in which a surprising amount of intrinsic linear heterogeneity may be obscured by MPL measurements of insufficient resolution, and by the negative stains used for imaging fibrils by electron microscopy.

[1]  R. Wetzel,et al.  Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. , 2010, Journal of molecular biology.

[2]  J. Johansson,et al.  Effects of Congo red on aβ(1-40) fibril formation process and morphology. , 2010, ACS chemical neuroscience.

[3]  Chimie.  ACS Chemical Neuroscience , 2010 .

[4]  N. Grigorieff,et al.  Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structures , 2009, Proceedings of the National Academy of Sciences.

[5]  J. Kelly,et al.  Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity , 2009, Proceedings of the National Academy of Sciences.

[6]  R. Tycko,et al.  Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy , 2009, Proceedings of the National Academy of Sciences.

[7]  S. Ludtke,et al.  Interprotofilament interactions between Alzheimer's Aβ1–42 peptides in amyloid fibrils revealed by cryoEM , 2009, Proceedings of the National Academy of Sciences.

[8]  N. Grigorieff,et al.  Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. , 2009, Journal of molecular biology.

[9]  Rudy M. Baum,et al.  The Chemistry Of Biology , 2008 .

[10]  Richard D. Leapman,et al.  Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[11]  M. Arimon,et al.  Sulfated Polysaccharides Promote the Assembly of Amyloid β1–42 Peptide into Stable Fibrils of Reduced Cytotoxicity* , 2008, Journal of Biological Chemistry.

[12]  N. Grigorieff,et al.  Paired β-sheet structure of an Aβ(1-40) amyloid fibril revealed by electron microscopy , 2008, Proceedings of the National Academy of Sciences.

[13]  P. Axelsen,et al.  Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product. , 2008, Journal of molecular biology.

[14]  L. Addadi,et al.  Chirality of amyloid suprastructures. , 2008, Journal of the American Chemical Society.

[15]  R. Leapman,et al.  Quantitative STEM mass measurement of biological macromolecules in a 300 kV TEM , 2007, Journal of microscopy.

[16]  R. Wetzel,et al.  Polymorphism in the intermediates and products of amyloid assembly. , 2007, Current opinion in structural biology.

[17]  R. Wetzel,et al.  Plasticity of amyloid fibrils. , 2007, Biochemistry.

[18]  N. Grigorieff,et al.  Quaternary structure of a mature amyloid fibril from Alzheimer's Abeta(1-40) peptide. , 2006, Journal of molecular biology.

[19]  A. Nagy,et al.  Mechanical manipulation of Alzheimer’s amyloid β1–42 fibrils , 2006 .

[20]  R. Tycko,et al.  Polymorphic fibril formation by residues 10-40 of the Alzheimer's beta-amyloid peptide. , 2006, Biophysical journal.

[21]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[22]  P. Hough,et al.  High-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers , 2006 .

[23]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[24]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[25]  Louise C Serpell,et al.  Structures for amyloid fibrils , 2005, The FEBS journal.

[26]  J. Hašek,et al.  Cold-active β-galactosidase from Arthrobacter sp. C2-2 forms compact 660 kDa hexamers : Crystal structure at 1.9 Å resolution , 2005 .

[27]  R. Wetzel,et al.  Thermodynamics of Aβ(1−40) Amyloid Fibril Elongation† , 2005 .

[28]  E. Giralt,et al.  Fine structure study of Aβ1–42 fibrillogenesis with atomic force microscopy , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[30]  R. Wetzel,et al.  An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking. , 2004, Biochemistry.

[31]  L. Wan,et al.  AFM and STM study of β-amyloid aggregation on graphite , 2003 .

[32]  S. Maiti,et al.  The Amyloid β Peptide (Aβ1-40) Is Thermodynamically Soluble at Physiological Concentrations† , 2003 .

[33]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Leapman,et al.  Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. , 2002, Biochemistry.

[35]  I. Kang,et al.  Methionine 35 Oxidation Reduces Fibril Assembly of the Amyloid Aβ-(1–42) Peptide of Alzheimer's Disease* , 2002, The Journal of Biological Chemistry.

[36]  Christopher M. Dobson,et al.  The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Serpell,et al.  Alzheimer's amyloid fibrils: structure and assembly. , 2000, Biochimica et biophysica acta.

[38]  S. Müller,et al.  Studies on the in Vitro Assembly of Aβ 1–40: Implications for the Search for Aβ Fibril Formation Inhibitors , 2000 .

[39]  T. Benzinger,et al.  Two-Dimensional Structure of β-Amyloid(10−35) Fibrils† , 2000 .

[40]  U. Aebi,et al.  Molecular mass determination by STEM and EFTEM: a critical comparison , 1999 .

[41]  Peter T. Lansbury,et al.  Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .

[42]  A. Roher,et al.  Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease. , 1998, Protein engineering.

[43]  K. Chou,et al.  A Model for Structure-Dependent Binding of Congo Red to Alzheimer β-Amyloid Fibrils , 1998, Neurobiology of Aging.

[44]  P. Lansbury,et al.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.

[45]  S. Müller,et al.  Mass Determination by Inelastic Electron Scattering in an Energy-Filtering Transmission Electron Microscope with Slow-Scan CCD Camera , 1997 .

[46]  M. Emmerling,et al.  Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[47]  P. Lansbury,et al.  Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. , 1992, Biochemistry.

[48]  D. Selkoe,et al.  Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.

[49]  H. Mantsch,et al.  Beware of proteins in DMSO. , 1991, Biochimica et biophysica acta.

[50]  D. Selkoe,et al.  Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Keiichi Namba,et al.  Structure of tobacco mosaic virus at 3.6 A resolution: implications for assembly. , 1986, Science.

[52]  Y. Shechter,et al.  Selective oxidation and reduction of methionine residues in peptides and proteins by oxygen exchange between sulfoxide and sulfide. , 1986, The Journal of biological chemistry.

[53]  G. Glenner,et al.  X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS , 1968, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[54]  G. Bahr,et al.  A Photometric Procedure for Weight Determination of Submicroscopic Particles Quantitative Electron Microscopy , 1962 .

[55]  Taija M. Kiviharju-af Hällström,et al.  Eturauhassyöpäalttiuden taustalla DNA-vauriovasteen puuttuminen: [Proc Natl Acad Sci USA in press] , 2007 .

[56]  Peter T. Lansbury,et al.  Observation of metastable Aβ amyloid protofibrils by atomic force microscopy , 1997 .

[57]  D. Selkoe,et al.  Isolation of paired helical filaments and amyloid fibers from human brain. , 1986, Methods in enzymology.

[58]  J F Hainfeld,et al.  Mass mapping with the scanning transmission electron microscope. , 1986, Annual review of biophysics and biophysical chemistry.